Skip to main content
. 2017 Nov 2;25(9):1463–1470. doi: 10.3727/096504017X14878518291077

Figure 6.

Figure 6

PCA inactivates AKT/ERK pathways by regulation of miR-133b. (A) mRNA and (B) protein levels of p/t-AKT (p308 or p473), p/t-ERK, and p/t-S6 were significantly decreased by PCA, whereas PCA + miR-133b inhibitor significantly elevated these levels. *p or #p < 0.05, **p < 0.01.